These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11747986)

  • 1. Role of TGF-beta family in osteoclastogenesis induced by RANKL.
    Koseki T; Gao Y; Okahashi N; Murase Y; Tsujisawa T; Sato T; Yamato K; Nishihara T
    Cell Signal; 2002 Jan; 14(1):31-6. PubMed ID: 11747986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressant rapamycin, alone or with transforming growth factor-beta, enhances osteoclast differentiation of RAW264.7 monocyte-macrophage cells in the presence of RANK-ligand.
    Shui C; Riggs BL; Khosla S
    Calcif Tissue Int; 2002 Nov; 71(5):437-46. PubMed ID: 12202955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
    Sugatani T; Alvarez UM; Hruska KA
    J Cell Biochem; 2003 Sep; 90(1):59-67. PubMed ID: 12938156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
    Rahman MM; Bhattacharya A; Fernandes G
    J Lipid Res; 2006 Aug; 47(8):1739-48. PubMed ID: 16702601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
    Koide M; Murase Y; Yamato K; Noguchi T; Okahashi N; Nishihara T
    Biochem Biophys Res Commun; 1999 May; 259(1):97-102. PubMed ID: 10334922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function.
    Jimi E; Akiyama S; Tsurukai T; Okahashi N; Kobayashi K; Udagawa N; Nishihara T; Takahashi N; Suda T
    J Immunol; 1999 Jul; 163(1):434-42. PubMed ID: 10384146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation.
    Park EK; Kim MS; Lee SH; Kim KH; Park JY; Kim TH; Lee IS; Woo JT; Jung JC; Shin HI; Choi JY; Kim SY
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1472-80. PubMed ID: 15555594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts.
    Otsuka E; Notoya M; Hagiwara H
    Calcif Tissue Int; 2003 Jul; 73(1):72-7. PubMed ID: 14506957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.
    Asai K; Funaba M; Murakami M
    Cell Biochem Funct; 2014 Jul; 32(5):401-9. PubMed ID: 24519885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous production of TGF-beta is essential for osteoclastogenesis induced by a combination of receptor activator of NF-kappa B ligand and macrophage-colony-stimulating factor.
    Kaneda T; Nojima T; Nakagawa M; Ogasawara A; Kaneko H; Sato T; Mano H; Kumegawa M; Hakeda Y
    J Immunol; 2000 Oct; 165(8):4254-63. PubMed ID: 11035059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
    Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
    J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid multiparameter approach to study factors that regulate osteoclastogenesis: demonstration of the combinatorial dominant effects of TNF-alpha and TGF-ss in RANKL-mediated osteoclastogenesis.
    Huang W; Drissi MH; O'Keefe RJ; Schwarz EM
    Calcif Tissue Int; 2003 Dec; 73(6):584-93. PubMed ID: 14517717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in enhancement of osteoclast formation by activin-A.
    Kajita T; Ariyoshi W; Okinaga T; Mitsugi S; Tominaga K; Nishihara T
    J Cell Biochem; 2018 Aug; 119(8):6974-6985. PubMed ID: 29737562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of osteoclastogenesis and RANK expression by TGF-beta1.
    Yan T; Riggs BL; Boyle WJ; Khosla S
    J Cell Biochem; 2001 Aug 1-9; 83(2):320-5. PubMed ID: 11573248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase.
    Glantschnig H; Fisher JE; Wesolowski G; Rodan GA; Reszka AA
    Cell Death Differ; 2003 Oct; 10(10):1165-77. PubMed ID: 14502240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
    Nagata N; Kitaura H; Yoshida N; Nakayama K
    Bone; 2003 Oct; 33(4):721-32. PubMed ID: 14555278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.